Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-26 Sale |
2023-01-30 6:40 pm |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer |
1,697 | $5.0799 | $8,621 | 11,853 (Direct) |
View |
| 2023-01-23 Sale |
2023-01-25 5:50 pm |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer |
1,309 | $5.3381 | $6,988 | 7,610 (Direct) |
View |
| 2022-12-06 Sale |
2022-12-09 7:37 pm |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Interim CFO/CAO/VP of Finance |
910 | $4.775 | $4,345 | 6,519 (Direct) |
View |
| 2021-11-30 Sale |
2021-12-02 06:30 am |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance |
29,790 | $0.5353 | $15,947 | 214,368 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-12 8:44 pm |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP Finance |
4,842 | $1.04 | $5,036 | 52,158 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-04-12 Exercise |
2023-04-14 7:17 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer |
50,000 | $0 | 61,853 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 5:11 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-01-26 Exercise |
2023-01-30 6:40 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer |
5,940 | $0 | 11,853 (Direct) |
View |
| 2023-01-23 Exercise |
2023-01-25 5:50 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer |
4,365 | $0 | 7,610 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-09 7:37 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Interim CFO/CAO/VP of Finance |
3,476 | $0 | 6,519 (Direct) |
View |
| 2022-03-31 Option Award |
2022-03-31 5:15 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance |
120,000 | $0 | 120,000 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-28 07:00 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-02 06:30 am |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance |
115,000 | $0 | 214,368 (Direct) |
View |
| 2021-09-29 Option Award |
2021-10-01 5:00 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance |
38,954 | $0 | 38,954 (Direct) |
View |
| 2021-09-29 Other |
2021-10-01 5:00 pm |
2015-07-09 2024-07-09 |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance |
290,000 | $0 | 38,954 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:42 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP Finance |
240,000 | $0 | 240,000 (Direct) |
View |
| 2021-05-10 Exercise |
2021-05-12 8:44 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP Finance |
19,000 | $0 | 52,158 (Direct) |
View |
| 2020-11-24 Option Award |
2020-11-27 5:09 pm |
N/A N/A |
TherapeuticsMD Inc. | TXMD | Donegan Michael C Chief Accounting Officer |
230,000 | $0 | 230,000 (Direct) |
View |